INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM);CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (C.N.R.S.);INSTITUT CURIE
发明人:
Sebastian Amigorena,Rhys Allan,Heidi Schreiber,Elina Zueva,Genevieve Almouzni
申请号：
US14349188
公开号：
US20150038496A1
申请日:
2012.10.03
申请国别(地区):
US
年份:
2015
代理人:
摘要：
The present invention relates to methods and pharmaceutical composition for the treatment of T-helper type 2 (Th2)-mediated diseases. More particularly, the present invention relates to an inhibitor of the Suv39h1-HP1a silencing pathway for use in the treatment of a T-helper type 2 (Th2)-mediated disease, in particular allergic asthma.
